{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:09:07Z","timestamp":1788901747006,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br Dent J"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1038\/sj.bdj.4811972","type":"journal-article","created":{"date-parts":[[2005,2,8]],"date-time":"2005-02-08T22:02:42Z","timestamp":1107900162000},"page":"83-85","source":"Crossref","is-referenced-by-count":60,"title":["Methotrexate and oral ulceration"],"prefix":"10.1038","volume":"198","author":[{"given":"G M J","family":"Deeming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Collingwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M N","family":"Pemberton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,1,22]]},"reference":[{"key":"BF4811972_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/0190-9622(91)70199-C","volume":"25","author":"EA Olsen","year":"1991","unstructured":"Olsen EA . The pharmacology of methotrextate. J Am Acad Dermatol 1991; 25: 306\u2013318.","journal-title":"J Am Acad Dermatol"},{"key":"BF4811972_CR2","unstructured":"British National Formulary. 45. London: BMA, RPS, 2003."},{"key":"BF4811972_CR3","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1572-0241.2003.07305.x","volume":"98","author":"O Schroder","year":"2003","unstructured":"Schroder O, Stein J . Low dose methotrexate in inflammatory bowel disease: current status and future directions. Am J Gastroenterol 2003; 98: 530\u2013537.","journal-title":"Am J Gastroenterol"},{"key":"BF4811972_CR4","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1136\/bjo.85.10.1220","volume":"85","author":"JR Smith","year":"2001","unstructured":"Smith JR, Rosembaum JT . A role for methotrexate in the management of non-infectious orbital inflammatory disease. Br J Ophthalmol 2001; 85: 1220\u20131224.","journal-title":"Br J Ophthalmol"},{"key":"BF4811972_CR5","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","volume":"359","author":"HK Choi","year":"2002","unstructured":"Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F . Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002; 359: 1173\u20131177.","journal-title":"Lancet"},{"key":"BF4811972_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2165\/00002512-200017040-00002","volume":"17","author":"JJ Knox","year":"2000","unstructured":"Knox JJ, Puodziunas ALV, Feld R . Chemotherapy-induced oral mucositis: prevention and management. Drugs Aging 2000; 17: 257\u2013267.","journal-title":"Drugs Aging"},{"key":"BF4811972_CR7","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0889-857X(05)70365-3","volume":"23","author":"SG West","year":"1997","unstructured":"West SG . Methotrexate toxicity. Rheum Dis Clin North Am 1997; 23: 883\u2013915.","journal-title":"Rheum Dis Clin North Am"},{"key":"BF4811972_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/bmj.327.7406.70","volume":"327","author":"S Major","year":"2003","unstructured":"Major S . UK introduces measures to reduce errors with methotrexate. Br Med J 2003; 327: 70.","journal-title":"Br Med J"},{"key":"BF4811972_CR9","first-page":"188","volume":"18","author":"G Singh","year":"1991","unstructured":"Singh G, Fries JF, Williams CA, Zatarain E, Spitz P, Bloch A . Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis. J Rheumatol 1991; 18: 188\u2013194.","journal-title":"J Rheumatol"},{"key":"BF4811972_CR10","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/bmj.326.7383.266","volume":"326","author":"M Sosin","year":"2003","unstructured":"Sosin M, Handa S . Low dose methotrexate and bone marrow suppression. Br Med J 2003; 326: 266\u2013267.","journal-title":"Br Med J"},{"key":"BF4811972_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/art.1780350203","volume":"35","author":"JM Kremer","year":"1992","unstructured":"Kremer JM, Phelps CT . Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Arthritis Rheum 1992; 35: 138\u2013145.","journal-title":"Arthritis Rheum"},{"key":"BF4811972_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/BF02229648","volume":"15","author":"A Ince","year":"1996","unstructured":"Ince A, Yazici Y, Hamuryudan V, Yazici H . The frequency and clinical characteristics of methotrexate (MTX) oral toxicity in rheumatoid arthritis (RA): A masked and controlled study. Clin Rheumatol 1996; 15: 491\u2013494.","journal-title":"Clin Rheumatol"},{"key":"BF4811972_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0163-7258(84)90024-X","volume":"25","author":"R Jackson","year":"1984","unstructured":"Jackson R . Biological effects of folic acid antagonists with antineoplastic activity. Pharmacol Ther 1984; 25: 61\u201382.","journal-title":"Pharmacol Ther"},{"key":"BF4811972_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/art.1780360609","volume":"36","author":"JB Shirozky","year":"1993","unstructured":"Shirozky JB, Neville C, Esdaile JM et al. Low-dose methotrexate with leucovirin (folinic acid) in the management of rheumatoid arthritis: results of a muticenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum 1993; 36: 795\u2013803.","journal-title":"Arthritis Rheum"},{"key":"BF4811972_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/0049-0172(91)90033-V","volume":"20","author":"KA Stewart","year":"1991","unstructured":"Stewart KA, Mackenzie AH, Clough JD, Wilke WS . Folate supplementation in methotrexate-treated rheumatoid arthritis patients. Semin Arthritis Rheum 1991; 20: 332\u2013338.","journal-title":"Semin Arthritis Rheum"},{"key":"BF4811972_CR16","first-page":"36","volume":"25","author":"Z Ortiz","year":"1998","unstructured":"Ortiz Z, Shea B, Suarez-Almazor M, Moher D, Wells GA, Tugwell P . The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials. J Rheumatol 1998; 25: 36\u201343.","journal-title":"J Rheumatol"},{"key":"BF4811972_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/030097401300162888","volume":"30","author":"GKM Endresen","year":"2001","unstructured":"Endresen GKM, Husby G . Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis. Scand J Rheumatol 2001; 30: 129\u2013134.","journal-title":"Scand J Rheumatol"},{"key":"BF4811972_CR18","doi-asserted-by":"publisher","first-page":"833","DOI":"10.7326\/0003-4819-121-11-199412010-00002","volume":"121","author":"SL Morgan","year":"1994","unstructured":"Morgan SL, Baggott JE, Vaughan WH et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis: a double-blind, placebo-controlled trial. Ann Intern Med 1994; 121: 833\u2013841.","journal-title":"Ann Intern Med"}],"container-title":["British Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/4811972.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/4811972","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/4811972.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T01:29:23Z","timestamp":1684373363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4811972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["BF4811972"],"URL":"https:\/\/doi.org\/10.1038\/sj.bdj.4811972","relation":{},"ISSN":["0007-0610","1476-5373"],"issn-type":[{"value":"0007-0610","type":"print"},{"value":"1476-5373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}